Department of General Surgery, Glan Clwyd Hospital, Rhyl, Denbighshire.
Department of General Surgery, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham.
Surg Laparosc Endosc Percutan Tech. 2020 Apr;30(2):93-105. doi: 10.1097/SLE.0000000000000746.
The objective of this study was to compare the outcomes of laparoscopic and open liver resection for tumors in the posterosuperior segments.
We performed a systematic review in accordance with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement standards. We conducted a search of electronic information sources to identify all studies comparing outcomes of laparoscopic and open liver resection for tumors in the posterosuperior segments. We used the Risk Of Bias In Nonrandomized Studies-of Interventions (ROBINS-I) tool to assess the risk of bias of the included studies. Fixed-effect or random-effects models were applied to calculate pooled outcome data.
We identified 11 observational studies, enrolling a total of 1023 patients. The included population in both groups were comparable in terms of baseline characteristics. Laparoscopic approach was associated with lower risks of total complications [odds ratio (OR): 0.45; 95% confidence interval (CI): 0.33, 0.61; P<0.00001], major complications (Dindo-Clavien III or more) (OR: 0.52; 95% CI: 0.36, 0.73; P=0.0002), and intraoperative blood loss [mean difference (MD): -114.71; 95% CI: -165.64, -63.79; P<0.0001]. Laparoscopic approach was associated with longer operative time (MD: 50.28; 95% CI: 22.29, 78.27; P=0.0004) and shorter length of hospital stay (MD: -2.01; 95% CI: -2.09, -1.92; P<0.00001) compared with open approach. There was no difference between the 2 groups in terms of need for blood transfusion (OR: 1.23; 95% CI: 0.75, 2.02; P=0.41), R0 resection (OR: 1.09; 95% CI: 0.66, 1.81; P=0.72), postoperative mortality (risk difference: -0.00; 95% CI: -0.02, 0.02; P=0.68), and need for readmission (OR: 0.70; 95% CI: 0.19, 2.60; P=0.60). In terms of oncological outcomes, there was no difference between the groups in terms disease recurrence (OR: 1.58; 95% CI: 0.95, 2.63; P=0.08), overall survival (OS) at maximum follow-up (OR: 1.09; 95% CI: 0.66, 1.81; P=0.73), 1-year OS (OR: 1.53; 95% CI: 0.48, 4.92; P=0.47), 3-year OS (OR: 1.26; 95% CI: 0.67, 2.37; P=0.48), 5-year OS (OR: 0.91; 95% CI: 0.41, 1.99; P=0.80), disease-free survival (DFS) at maximum follow-up (OR: 0.91; 95% CI: 0.65, 1.27; P=0.56), 1-year DFS (OR: 1.04; 95% CI: 0.60, 1.81; P=0.88), 3-year DFS (OR: 1.13; 95% CI: 0.75, 1.69; P=0.57), and 5-year DFS (OR: 0.73; 95% CI: 0.44, 1.24; P=0.25).
Compared with the open approach in liver resection for tumors in the posterosuperior segments, the laparoscopic approach seems to be associated with a lower risk of postoperative morbidity, less intraoperative blood loss, and shorter length of hospital stay with comparable survival and oncological outcomes. The best available evidence is derived from observational studies with moderate quality; therefore, high-quality randomized controlled trials with adequate statistical power are required to provide a more robust basis for definite conclusions.
本研究旨在比较后上肝段肿瘤行腹腔镜与开腹肝切除术的结果。
我们根据系统评价和荟萃分析报告(PRISMA)标准进行了系统综述。我们对电子信息源进行了检索,以确定所有比较后上肝段肿瘤行腹腔镜与开腹肝切除术结果的研究。我们使用非随机干预研究的风险偏倚(ROBINS-I)工具来评估纳入研究的风险偏倚。采用固定效应或随机效应模型计算汇总结果数据。
我们确定了 11 项观察性研究,共纳入 1023 名患者。两组的基线特征具有可比性。腹腔镜方法与总并发症风险降低相关[比值比(OR):0.45;95%置信区间(CI):0.33,0.61;P<0.00001]、主要并发症(Dindo-Clavien III 级或更高级别)(OR:0.52;95%CI:0.36,0.73;P=0.0002)和术中出血量[平均差值(MD):-114.71;95%CI:-165.64,-63.79;P<0.0001]。与开腹方法相比,腹腔镜方法的手术时间更长(MD:50.28;95%CI:22.29,78.27;P=0.0004),住院时间更短(MD:-2.01;95%CI:-2.09,-1.92;P<0.00001)。两组间输血需求(OR:1.23;95%CI:0.75,2.02;P=0.41)、R0 切除(OR:1.09;95%CI:0.66,1.81;P=0.72)、术后死亡率(风险差异:-0.00;95%CI:-0.02,0.02;P=0.68)和再入院需求(OR:0.70;95%CI:0.19,2.60;P=0.60)无差异。在肿瘤学结果方面,两组间疾病复发(OR:1.58;95%CI:0.95,2.63;P=0.08)、最大随访时的总生存(OS)(OR:1.09;95%CI:0.66,1.81;P=0.73)、1 年 OS(OR:1.53;95%CI:0.48,4.92;P=0.47)、3 年 OS(OR:1.26;95%CI:0.67,2.37;P=0.48)、5 年 OS(OR:0.91;95%CI:0.41,1.99;P=0.80)、最大随访时的无病生存(DFS)(OR:0.91;95%CI:0.65,1.27;P=0.56)、1 年 DFS(OR:1.04;95%CI:0.60,1.81;P=0.88)、3 年 DFS(OR:1.13;95%CI:0.75,1.69;P=0.57)和 5 年 DFS(OR:0.73;95%CI:0.44,1.24;P=0.25)无差异。
与后上肝段肿瘤的开腹肝切除术相比,腹腔镜方法似乎与术后发病率较低、术中出血量较少、住院时间较短相关,且生存和肿瘤学结果相当。最佳现有证据来自于质量中等的观察性研究;因此,需要高质量的随机对照试验,以提供更有力的基础来得出明确的结论。